Dr Reddy’s Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022.
The drug firm had reported a net profit of Rs 706 crore in the October-December period of the previous fiscal.
Revenue from operations rose to Rs 6,770 crore during the period under review as against Rs 5,320 crore in the year-ago period, Dr Reddy’s Laboratories said in a regulatory filing.

BookmarkUs

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy